Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord

No abstract is available for this paper.

• Publication year

  2018

• Venue

  British Journal of Pharmacology

• Publication date

  2018-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.14189PMID 29500820PMCID PMC5980266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord

  2018cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

  2017cited by this paper
• Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand‐gated ion channels

  2017cited by this paper
• Electrophysiological evidence of increased glycine receptor-mediated phasic and tonic inhibition by blockade of glycine transporters in spinal superficial dorsal horn neurons of adult mice.

  2017influential reference
• New approaches to target glycinergic neurotransmission for the treatment of chronic pain.

  2017cited by this paper
• THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

  2017cited by this paper
• Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain

  2016cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Targeted Ablation, Silencing, and Activation Establish Glycinergic Dorsal Horn Neurons as Key Components of a Spinal Gate for Pain and Itch

  2015cited by this paper
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

  2015cited by this paper
• Experimental design and analysis and their reporting: new guidance for publication in BJP

  2015cited by this paper
• Glycine transport inhibitors for the treatment of pain.

  2014cited by this paper
• Oleoyl‐l‐carnitine inhibits glycine transport by GlyT2

  2013influential reference
• Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain

  2013cited by this paper
• Fast synaptic inhibition in spinal sensory processing and pain control.

  2012influential reference
• Molecular Sites for the Positive Allosteric Modulation of Glycine Receptors by Endocannabinoids

  2011cited by this paper
• Reporting : The ARRIVE Guidelines for Reporting Animal Research

  2010cited by this paper
• Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research

  2010cited by this paper
• N‐arachidonyl‐glycine modulates synaptic transmission in superficial dorsal horn

  2010cited by this paper
• Functional 'glial' GLYT1 glycine transporters expressed in neurons.

  2010cited by this paper
• Spinal Antiallodynia Action of Glycine Transporter Inhibitors in Neuropathic Pain Models in Mice

  2008influential reference
• Actions of N-arachidonyl-glycine in a rat neuropathic pain model.

  2008cited by this paper
• Actions of N-arachidonyl-glycine in a rat inflammatory pain model

  2007cited by this paper
• N‐Arachidonyl‐glycine inhibits the glycine transporter, GLYT2a

  2006cited by this paper
• Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice

  2005cited by this paper
• Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord

  2004influential reference
• Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality.

  2003influential reference
• Facilitation of Spinal NMDA Receptor Currents by Spillover of Synaptically Released Glycine

  2003cited by this paper
• Why glycine transporters have different stoichiometries

  2002cited by this paper
• Strychnine‐sensitive modulation is selective for non‐noxious somatosensory input in the spinal cord of the rat

  1996cited by this paper
• Strychnine-dependent allodynia in the urethane-anesthetized rat is segmentally distributed and prevented by intrathecal glycine and betaine.

  1995cited by this paper
• Regional Distribution and Developmental Variation of the Glycine Transporters GLYT1 and GLYT2 in the Rat CNS

  1995cited by this paper
• The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord.

  1994cited by this paper
• Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes.

  1992cited by this paper
• Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists

  1989influential reference
• Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.

  1989cited by this paper

• GPR30 in spinal cholecystokinin-positive neurons modulates neuropathic pain

  2025cites this paper
• Reduction of postoperative pain and opioid consumption by VVZ-149, first-in-class analgesic molecule: A confirmatory phase 3 trial of laparoscopic colectomy.

  2024cites this paper
• Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine–Glutamate Crosstalk

  2024cites this paper
• Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats

  2022cites this paper
• Bupivacaine reduces GlyT1 expression by potentiating the p-AMPKα/BDNF signalling pathway in spinal astrocytes of rats

  2022cites this paper
• Distinct synaptic mechanisms underlying the analgesic effects of GABA transporter subtypes 1 and 3 inhibitors in the spinal dorsal horn.

  2021cites this paper
• Microglia and Inhibitory Circuitry in the Medullary Dorsal Horn: Laminar and Time-Dependent Changes in a Trigeminal Model of Neuropathic Pain

  2021cites this paper
• A Glra3 phosphodeficient mouse mutant establishes the critical role of protein kinase A–dependent phosphorylation and inhibition of glycine receptors in spinal inflammatory hyperalgesia

  2021cites this paper
• Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy

  2021influential citation
• ArticleAssessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter

  2021cites this paper
• A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors

  2020cites this paper
• MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand

  2020cites this paper
• Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain

  2020cites this paper
• Glycine transporter inhibitors: a new avenue for managing neuropathic pain.

  2019cites this paper
• Recent advances in targeting ion channels to treat chronic pain

  2018cites this paper
• Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord

  2018cites this paper